Amarin Corp Plc (AMRN)

[alm2]

If they have very good intelligence on generics activity and thus when they are about to launch - that would be the ideal time to obtain injunction - an immediate threat to their Amarins commercial rights - and hell let the generics waste some more money on all that goes with getting ready to launch- but if you were Hikma what would you say the commercial gain would be to them actually launching pre appeal decision ? And what are the commercial risks in so doing ? They are a business wishing to make a profit so they will balance these commercial risks and rewards - I am not privy to their financial analysis - but my view is they are most unlikely to try to launch pre appeal outcome
This whole story now turns on appeal outcome as far as USA market concerned -
Alm